13F-HR filed by Opaleye Management Inc.
Opaleye Management Inc. filed this 13F-HR for the quarter ended 2014-03-31, filed 2014-05-15, with 30 holding rows worth $135,373,000.
- Accession
- 0001546927-14-000115
- Filer
- CIK 1595855
- Filed
- 2014-05-15
- Accepted by EDGAR
- acceptance time not in the bulk data set
- Ingested
- Source
- SEC quarterly data set
13F report for Q1 2014
A holdings report, 30 entries on the cover page, a total value of $135,373,000 stated on the cover page (in dollars after the unit check, H1), rows summing to $135,373,000 with VALUE read as thousands by filing date, 13F file number 028-15896. The quarter's positions are built on this report. The resolved quarter.
The information table after summing rows of one CUSIP and put or call (H4), with the CUSIP and issuer name as filed. Values in dollars after the unit check (method).
| Issuer as filed | CUSIP | Class | Amount | Value | Value read as | Type |
|---|---|---|---|---|---|---|
| RETROPHIN INC | 761299106 | COM | 1,153,230 | $24,448,000 | thousands by filing date | |
| ARIAD PHARMACEUTICALS INC | 04033A100 | COM | 1,670,000 | $13,460,000 | thousands by filing date | |
| CHIMERIX INC COM | 16934W106 | Stock | 536,000 | $12,242,000 | thousands by filing date | |
| PHARMACYCLICS INC | 716933106 | COM | 115,000 | $11,525,000 | thousands by filing date | |
| INSPIREMD INC | 45779A309 | COM | 2,150,000 | $6,560,000 | thousands by filing date | |
| OMEROS CORP | 682143102 | COM | 500,100 | $6,036,000 | thousands by filing date | |
| CEMPRA INC | 15130J109 | COM | 480,000 | $5,544,000 | thousands by filing date | |
| BIND THERAPEUTICS INC | 05548N107 | Cmn | 427,000 | $5,107,000 | thousands by filing date | |
| NPS PHARMACEUTICALS INC | 62936P103 | COM | 150,000 | $4,490,000 | thousands by filing date | |
| GENMARK DIAGNOSTICS INC | 372309104 | COM | 435,000 | $4,324,000 | thousands by filing date | |
| CARDIOVASCULAR SYSTEMS INC | 141619106 | COMMON STOCK | 135,000 | $4,292,000 | thousands by filing date | |
| NOVADAQ TECHNOLOGIES INC COMMON | 66987G102 | COM | 167,600 | $4,116,000 | thousands by filing date | |
| STANDARD BIOTOOLS INC | 34385P108 | COM | 90,000 | $3,966,000 | thousands by filing date | |
| BIOLINERX LTD-SPONS ADR | 09071M106 | SPON | 1,451,000 | $3,236,000 | thousands by filing date | |
| CATALYST PHARMACEUTICALS INC | 14888U101 | COM | 1,378,584 | $3,116,000 | thousands by filing date | |
| EPIZYME INC | 29428V104 | COM | 115,500 | $2,630,000 | thousands by filing date | |
| LIGAND PHARMACEUTICALS INC | 53220K504 | COM NEW | 35,000 | $2,354,000 | thousands by filing date | |
| GERON CORP | 374163103 | COM | 1,100,000 | $2,299,000 | thousands by filing date | |
| FLEXION THERAPEUTICS INC | 33938J106 | COM | 135,500 | $2,229,000 | thousands by filing date | |
| EVOKE PHARMA INC | 30049G104 | COM | 233,400 | $1,956,000 | thousands by filing date | |
| CELGENE CORP | 151020112 | RIGHT 12/31/2030 | 660,000 | $1,881,000 | thousands by filing date | |
| TETRAPHASE PHARMACEUTICALS INC | 88165N105 | COMMON STOCK | 160,000 | $1,757,000 | thousands by filing date | |
| KALOBIOS PHARMACEUTICALS INC | 48344T100 | COM | 545,000 | $1,474,000 | thousands by filing date | |
| ARRAY BIOPHARMA INC COM | 04269X105 | Stock | 305,000 | $1,434,000 | thousands by filing date | |
| CODEXIS INC | 192005106 | COM | 698,300 | $1,425,000 | thousands by filing date | |
| CELATOR PHARMACEUTICALS INC | 15089R102 | Cmn | 325,000 | $1,031,000 | thousands by filing date | |
| MACROGENICS INC | 556099109 | COM | 30,000 | $838,000 | thousands by filing date | |
| AFFYMETRIX INC | 00826T108 | COM | 100,000 | $713,000 | thousands by filing date | |
| KIPS BAY MEDICAL INC | 49726K105 | COM | 777,531 | $540,000 | thousands by filing date | |
| SUNSHINE HEART INC | 86782u106 | COM | 60,000 | $350,000 | thousands by filing date |
Amendment chain
| Filing | Role | Filed | Accepted | Ingested |
|---|---|---|---|---|
| 13F-HR 0001546927-14-000115 | this filing | 2014-05-15 | acceptance time not in the bulk data set |